NPCE Latest Press Releases

-- February 20, 2026 --

NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026 Business Wire 4:30 PM

-- January 13, 2026 --

NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook Business Wire 7:30 AM

-- December 31, 2025 --

NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference Business Wire 9:00 AM

-- December 17, 2025 --

NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS System Indication for Idiopathic Generalized Epilepsy Business Wire 8:00 AM

-- December 8, 2025 --

NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy Business Wire 8:00 AM

-- December 2, 2025 --

NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting Business Wire 8:01 AM

-- November 24, 2025 --

NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services Business Wire 8:00 AM

-- November 4, 2025 --

NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance Business Wire 4:05 PM

-- October 22, 2025 --

NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025 Business Wire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software